Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a tablet game replace tiring motor tests for neuromuscular disease?

NCT ID NCT05227274

Diagnosis Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time

Summary

Researchers are testing whether a tablet-based, game-like version of the Motor Function Measure (MFM) gives consistent results compared with the standard paper-based scale. The study includes 70 people aged 2 to 60 with a confirmed neuromuscular disease. Participants complete the MFM three times: twice using the digital MFM-Play and once without it, with about a month between each assessment. The goal is to see if the digital version is reliable enough to use in future clinical trials while making assessments less burdensome for children.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a tablet-based, game-like version of the Motor Function Measure (MFM-Play)
What this could lead to
If it works, this could give children and adults with neuromuscular diseases a less tiring way to take part in motor function assessments during clinical trials.
What could go wrong
The digital version may not match the standard paper-based scale closely enough, and the study is small and early. Results may not apply to all neuromuscular conditions or age groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

70 people

The number who actually took part.

Started

Nov 2022

Finished

Jul 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with a follow-up in a French neuromuscular reference center

Ages

2 to 60 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with a neuromuscular disease confirmed by the clinic, electroneuromyography (ENMG), biology, muscular biopsy, or genetic * aged ≥ 2 yo and ≤ 60 yo * having been informed and not objecting to participating in the study (information and non-opposition of parents/holders of parental authority for minor patients) Exclusion Criteria: * participating in other interventional research with an exclusion period that is still ongoing or that may interfere with the results of this study * having had surgery or illness impacting their motor function within the last 6 months * having understanding and/or behavioral deficiencies preventing rigorous assessment * Patient placed under legal protection (this includes guardianship, curatorship and safeguard of justice)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neuromuscular diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

neuromuscular disease Patient Participation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neuromuscular diseases

Contacts and locations

Locations

  • Centre de référence MNM Adulte Saint Etienne - service neurologie CHU Hôpital Nord

    Saint-Priest-en-Jarez, 42270, France

  • Centre de référence des maladies neuromusculaires enfants Hôpital des enfants CHU de Toulouse

    Toulouse, 31059, France

  • Centre de référence maladies neuromusculaires Hôpital Morvan - CHRU de Brest

    Brest, 29200, France

  • Centre de référence maladies neuromusculaires Hôpital Salengro CHU Lille

    Lille, 59000, France

  • Consultation de pédiatrie- maladie neuromusculaire Hôpital Armand Trousseau APHP

    Paris, 75012, France

  • Consultation pluridisciplinaire MNM adulte Hôpital de la Croix Rousse, Groupement Hospitalier Nord HCL

    Lyon, 69004, France

  • ESEAN - APF France Handicap

    Nantes, 44200, France

  • Service de Médecine Physique et de Réadaptation Pédiatrique Hôpital Bellevue CHU Saint Etienne

    Saint-Etienne, 42000, France

  • Service de Médecine Physique et de Réadaptation Pédiatrique Hôpital Couple-Enfant CHU de Grenoble

    La Tronche, 38700, France

  • Service de Rééducation Fonctionnelle Pédiatrique - L'Escale - Hôpital Femme Mère Enfant, Hospices Civils de Lyon

    Bron, 69500, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.